Related Experiment Video
Updated: Aug 5, 2025

Monitoring Endoplasmic Reticulum Calcium Homeostasis Using a Gaussia Luciferase SERCaMP
Published on: September 6, 2015
Regulation of ErbB Receptors by the Ca2+ Sensor Protein Calmodulin in Cancer
1Cancer and Human Molecular Genetics Area-Oto-Neurosurgery Research Group, University Hospital La Paz Research Institute (IdiPAZ), Paseo de la Castellana 261, E-28046 Madrid, Spain.
Abstract:
Overexpression and mutations of the epidermal growth factor receptor (EGFR/ErbB1/HER1) and other tyrosine kinase receptors of the ErbB family (ErbB2/HER2, ErbB3/HER3 and ErbB4/HER4) play an essential role in enhancing the proliferation, the migratory capacity and invasiveness of many tumor cells, leading to cancer progression and increased malignancy. To understand these cellular processes in detail is essential to understand at a molecular level the signaling pathways and regulatory mechanisms controlling these receptors. In this regard, calmodulin (CaM) is a Ca2+-sensor protein that directly interacts with and regulates ErbB receptors, as well as some CaM-dependent kinases that also regulate these receptors, particularly EGFR and ErbB2, adding an additional layer of CaM-dependent regulation to this system. In this short review, an update of recent advances in this area is presented, covering the direct action of Ca2+/CaM on the four ErbB family members mostly in tumor cells and the indirect action of Ca2+/CaM on the receptors via CaM-regulated kinases. It is expected that further understanding of the CaM-dependent mechanisms regulating the ErbB receptors in future studies could identify new therapeutic targets in these systems that could help to control or delay cancer progression.
Insights
Calmodulin (CaM) regulates epidermal growth factor receptor (EGFR) family signaling pathways. Understanding CaM
Area of Science:
- Molecular biology
- Cell signaling
- Cancer research
Background:
- Epidermal growth factor receptor (EGFR) family, including EGFR/ErbB1, ErbB2, ErbB3, and ErbB4, are crucial in tumor cell proliferation, migration, and invasion.
- Dysregulation of ErbB receptors drives cancer progression and malignancy.
- Understanding the molecular mechanisms controlling ErbB receptors is vital for cancer research.
Purpose of the Study:
- To review recent advances in understanding calmodulin (CaM)-dependent regulation of ErbB receptors.
- To explore both direct and indirect mechanisms of CaM action on ErbB family members.
- To highlight the role of CaM in regulating signaling pathways in tumor cells.
Main Methods:
- Literature review of recent scientific advances.
- Analysis of direct Ca2+/CaM interactions with ErbB receptors.
- Examination of indirect Ca2+/CaM regulation via CaM-dependent kinases.
Main Results:
- Calmodulin (CaM) directly interacts with and regulates all four ErbB family members (EGFR/ErbB1, ErbB2, ErbB3, ErbB4).
- CaM also indirectly regulates EGFR and ErbB2 through CaM-dependent kinases.
- These CaM-dependent mechanisms add a regulatory layer to ErbB signaling in tumor cells.
Conclusions:
- Ca2+/CaM plays a significant role in regulating ErbB receptor activity in cancer.
- Further research into CaM-dependent mechanisms could reveal novel therapeutic targets.
- Targeting CaM-ErbB interactions may offer strategies to control or delay cancer progression.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Negative Regulator Molecules

